The latest news from academia, regulators
research labs and other things of interest
Posted: January 27, 2009
Pii Launches Drug Delivery Solutions Initiative
(Nanowerk News) Since its inception, Pii has built considerable expertise in drug delivery, including extensive experience with conventional controlled release formulation approaches, a portfolio of Pii-sponsored technologies and programs involving third-party platforms – its alliance with Penwest Pharmaceuticals for TIMERx technology being an example.
The strategy for Pii Drug Delivery Solutions is to provide dedicated business development, centers of technical excellence, proactive partnering and integrated support from Pii core resources. Pii believes that its exciting portfolio of in-house and partnered drug delivery technologies can be put to work to assist clients with their product development needs, be they early-stage drug candidate optimization through to the revitalization of a marketed compound.
Steve King, Senior Vice President said, “Our dedicated business development team lead by Robin Mitchell and Susan Wiggins has extensive experience in drug delivery and contract services. We aim to proactively bring creative problem solving solutions and product concepts to our clients. We already have a very powerful portfolio of technology platforms at our disposal and intend to build on this during 2009.”
“Pii has quietly developed some impressive technologies of its own – nanoparticle formulations and MedCrystalForms’ mixed phase co-crystals for enhanced drug bioavailability for example. And, through our partnerships with companies like Penwest, we can tackle a broad range of controlled release challenges too”, said Robin Mitchell, Senior Director Drug Delivery Solutions adding, “Susan Wiggins and I are very excited about the role that we can play to strengthen our clients business success in today’s very competitive markets”.
The new website, which you are currently exploring, is launched today and introduces Pii Drug Delivery Solutions. The site will feature Pii’s growing portfolio of capabilities and resources as it expands.
Source: Pharmaceutics International, Inc. (Pii) (press release)